|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�������������� |
|
����������������,�е� |
| ��������������� | |
|
�ź� |
|
�˾� |
| PubMed | |
|
Article by ZHANG Hong |
|
Article by GU Jun |
�����������������°е�Ľ�չ
�ź�, �˾�
�ڶ���ҽ��ѧ����ҽԺƤ���� �Ϻ� 200433
���������������ǽ鵼��֢��Ӧ�����߷�Ӧ��ϸ������,���й㷺������ѧ���ԡ�������,�����⿹��������������ҩ����о���չѸ�١������Ʀ������������ӡ�������������ǰ�����ɡ����Ѿ��ͷŵ����������������÷����Ҫ������Ŀǰ�о��ļ�����Ҫ�е㼰���ҩ�
New Research Targets of Anti-TNF alpha
Department of Dermatology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
Department of Dermatology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
Tumor necrosis factor-alpha(TNF-��) is a cytokine mediating inflammatory reaction and immune responses, and has various biological activities. Recently,the research on anti-TNF-�� drugs has developed rapidly. This article reviews the main targets of the present research and correlated drugs inhibiting the production or precursors of TNF-�� and antagonizing released TNF.
������Ȼ��ѧ��������(30271197)
[2] Remacle-Bonnet MM,Garrouste FL,Heller S,et al.Insulin-like growth factor-�� protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.Cancer Res,2000,60:2007-217.
[3] Coimbra R,Porcides RD,Melbostad H,et al.Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia.Surg Infect (Larchmt),2005,6:73-85.
[4] Douni E,Sfikakis PP,Haralambous S,et al.Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein:comparative analysis with dexamethasone,methotrexate and anti-TNF protocols.Arthritis Res Ther,2004,6:R65-R72.
[5] Sampaio EP,Hernandez MO,Carvalho DS,et al.Management of erythema nodosum leprosum by thalidomide:thalidomide analogues inhibit M.leprae-induced TNFalpha production in vitro.Biomed Pharmacother,2002,56:13-19.
[6] Minghetti PP,Blackburn WD Jr.Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines,matrix metalloproteinases,and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.J Rheumatol,2000,27:653-660.
[7] Dixit V,Mak TW.NF-kappaB signaling.Many roads lead to Madrid.Cell,2002,111:615-619.
[8] Yao FH,Yao XD,Li JJ,et al.Relationship between nuclear factor-KappaB activity and kidney injury in rats with postburn sepsis.Zhongguo Wei Zhong Bing Ji Jiu Yi Xue,2005,17:722-725.Chinese.
[9] Ockenfels HM,Schultewolter T,Ockenfels G,et al.The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.Br J Dermatol,1998,139:390-395.
[10] Stathopulos PB,Lu X,Shen J,et al.Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure.Am J Physiol Heart Circ Physiol,2001,280:H859-867.
[11] Loher F,Schmall K,Freytag P,et al.The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.J Pharmacol Exp Ther,2003,305:549-556.
[12] Ramnath N,Creaven PJ.Matrix metalloproteinase inhibitors.Curr Oncol Rep,2004,6:96-102.
[13] Nasatzky E,Rubinstein Y,Goultschin J,et al.The role of matrix metalloproteinases in the progression of periodontitis,and the use of specific inhibitors to these enzymes in the treatment of the periodontal disease.Refuat Hapeh Vehashinayim,2003,20:38-45,81.
[14] Syed S,Takimoto C,Hidalgo M,et al.A phase I and pharmacokinetic study of Col-3 (Metastat),an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties.Clin Cancer Res,2004,10:6512-6521.
[15] Gaur U,Aggarwal BB.Regulation of proliferation,survival and apoptosis by members of the TNF superfamily.Biochem Pharmacol,2003,66:1403-1408.